Hospital de Cabuenes

Gijón, Principality of Asturias 33203

2 studies enrolling now · 2 studies all time

What they study most

Monoclonal Gammopathy of Undetermined Significance (MGUS), Relapsed/Refractory Systemic Light Chain Amyloidosis, Smoldering Multiple Myeloma (SMM)

Studies at this site

• A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma — Recruiting now
• A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis) — Recruiting now